Balyasny Asset Management
PHAT icon

Balyasny Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Balyasny Asset Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$126K Sell
2025
Q1 		$287K Buy
2024
Q4 		– Sell
2024
Q3 		$1.19M Buy
2024
Q2 		$155K Buy
2022
Q4 		– Sell
2022
Q3 		$205K Buy